Pelthos Therapeutics Stock Net Asset
| PTHS Stock | 25.40 3.60 12.41% |
Fundamental analysis of Pelthos Therapeutics allows traders to better anticipate movements in Pelthos Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pelthos Therapeutics Company Net Asset Analysis
Pelthos Therapeutics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Pelthos Therapeutics Net Asset | 1.37 M |
Most of Pelthos Therapeutics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pelthos Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Pelthos Therapeutics has a Net Asset of 1.37 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all United States stocks is notably lower than that of the firm.
Pelthos Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pelthos Therapeutics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pelthos Therapeutics could also be used in its relative valuation, which is a method of valuing Pelthos Therapeutics by comparing valuation metrics of similar companies.Pelthos Therapeutics is currently under evaluation in net asset category among its peers.
Pelthos Fundamentals
| EBITDA | (7.17 M) | |||
| Net Income | (7.96 M) | |||
| Total Debt | 2.19 M | |||
| Cash Flow From Operations | (5.79 M) | |||
| Total Asset | 1.37 M | |||
| Retained Earnings | (21.47 M) | |||
| Working Capital | (2.71 M) | |||
| Net Asset | 1.37 M |
About Pelthos Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pelthos Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pelthos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pelthos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.